Literature DB >> 17409143

Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.

Timothy R Wagenaar1, Bernard Moss.   

Abstract

The proteins encoded by the A56R and K2L genes of vaccinia virus form a heterodimer (A56/K2) and have a fusion regulatory role as deletion or mutation of either causes infected cells to form large syncytia spontaneously. Here, we showed that syncytia formation is dependent on proteins of the recently described entry fusion complex (EFC), which are also required for virus-cell fusion and low-pH-triggered cell-cell fusion. This finding led us to consider that A56/K2 might prevent fusion by direct or indirect interaction with the EFC. To test this hypothesis, we made a panel of recombinant vaccinia viruses that have a tandem affinity purification tag attached to A56, K2, or the A28 EFC protein. Interaction between A56/K2 and the EFC was demonstrated by their copurification from detergent-treated lysates of infected cells and identification by mass spectrometry or Western blotting. In addition, a purified soluble transmembrane-deleted form of A56/K2 was shown to interact with the EFC. Tagged A56 did not interact with the EFC in the absence of K2, nor did tagged K2 interact with the EFC in the absence of A56. The finding that both A56 and K2 are required for efficient binding to the EFC fits well with prior experiments showing that mutation of either A56 or K2 results in spontaneous fusion of infected cells. Because A56 and K2 are located on the surface of infected cells, they are in position to interact with the EFC of released progeny virions and prevent back-fusion and syncytia formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409143      PMCID: PMC1900102          DOI: 10.1128/JVI.00274-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Inhibition of the complement cascade by the major secretory protein of vaccinia virus.

Authors:  G J Kotwal; S N Isaacs; R McKenzie; M M Frank; B Moss
Journal:  Science       Date:  1990-11-09       Impact factor: 47.728

2.  The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.

Authors:  R W Doms; R Blumenthal; B Moss
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.

Authors:  G J Kotwal; B Moss
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

5.  Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein.

Authors:  S C Gong; C F Lai; M Esteban
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

6.  Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants.

Authors:  M Seki; M Oie; Y Ichihashi; H Shida
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

7.  Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene.

Authors:  Tatiana G Senkevich; Brian M Ward; Bernard Moss
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.

Authors:  L G Payne
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

9.  Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum.

Authors:  R W Doms; G Russ; J W Yewdell
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

10.  Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER.

Authors:  J Lippincott-Schwartz; L C Yuan; J S Bonifacino; R D Klausner
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

View more
  40 in total

1.  Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Vaccinia mature virus fusion regulator A26 protein binds to A16 and G9 proteins of the viral entry fusion complex and dissociates from mature virions at low pH.

Authors:  Shu-Jung Chang; Ao-Chun Shih; Yin-Liang Tang; Wen Chang
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Aptamers recognizing glycosylated hemagglutinin expressed on the surface of vaccinia virus-infected cells.

Authors:  Parag Parekh; Zhiwen Tang; Peter C Turner; Richard W Moyer; Weihong Tan
Journal:  Anal Chem       Date:  2010-10-15       Impact factor: 6.986

5.  Two distinct low-pH steps promote entry of vaccinia virus.

Authors:  Alan C Townsley; Bernard Moss
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

6.  Vaccinia virus strain differences in cell attachment and entry.

Authors:  Zain Bengali; Alan C Townsley; Bernard Moss
Journal:  Virology       Date:  2009-05-09       Impact factor: 3.616

7.  Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.

Authors:  Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

8.  The vaccinia virus gene I2L encodes a membrane protein with an essential role in virion entry.

Authors:  R Jeremy Nichols; Eleni Stanitsa; Bethany Unger; Paula Traktman
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

9.  The Impact of Mass Spectrometry-Based Proteomics on Fundamental Discoveries in Virology.

Authors:  Todd M Greco; Benjamin A Diner; Ileana M Cristea
Journal:  Annu Rev Virol       Date:  2014-07-14       Impact factor: 10.431

10.  Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.

Authors:  Natasha M Girgis; Brian C Dehaven; Xin Fan; Kendra M Viner; Mohammad Shamim; Stuart N Isaacs
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.